News 20 mar 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
Aktuell 31 out 2023 Erfahrener Regulatory Compliance Partner Metecon eröffnet Schweizer Niederlassung in Bern Metecon hat Niederlassung in Bern eröffnet: Schweizer Hersteller von Medizinprodukten und IVD werden vor Ort bei der Regulatory Compliance und be...
News 25 out 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
Actualités 26 out 2022 Cordis va acquérir la medtech vaudoise MedAlliance pour USD 1,1 milliard Dans le cadre d’une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a signé un accord de sortie avec Cordis, un leader mondi...
News 26 out 2022 Cordis to acquire Vaud-based medtech MedAlliance for up to USD 1.1 billion In a total transaction of up to USD 1.135 billion, MedAlliance has signed an exit agreement with Cordis, a worldwide leader in interventional car...
Industry Report 24 mar 2021 Industry Report: Medtech in Korea The import rate in the medical device sector in Korea is higher than 60%. This presents vast business opportunities for Swiss exporters.
Branchenreport 24 mar 2021 Branchenreport: Medtech in Korea Die Importquote für medizinische Geräte liegt in Korea bei über 60%. Daraus ergeben sich weitreichende Geschäftschancen für Schweizer Exporteure....
Actualités 27 out 2021 ONWARD Medical entre en bourse et lève CHF 93 millions La spin-off de l'EPFL, ONWARD Medical, est entrée en bourse sur Euronext Bruxelles avec une cotation secondaire sur Euronext Amsterdam, portant l...
News 27 out 2021 ONWARD Medical goes public and raises CHF 93 million EPFL spin-off ONWARD Medical went public on Euronext Brussels with a secondary listing on Euronext Amsterdam, bringing the value of the company t...
Actualités 24 mar 2021 La société medtech MedAlliance lève plus de USD 50 millions pour commercialiser ses ballons à élution de médicament La société nyonnaise MedAlliance a levé plus de USD 50 millions en fonds propres pour son nouveau ballon qui permet une libération contrôlée et p...
News 25 set 2018 GLOBAL TRADE BRIEFING: Database for trade barriers Which of your target export markets have introduced new regulations that could create commercial opportunities or make it harder to supply foreig...
News 24 mar 2021 Medtech company MedAlliance raises over USD 50 million to commercialize drug-eluting balloons Vaud-based MedAlliance has raised over USD 50 Million in equity funding for its novel balloon that provides a controlled sustained release of a l...
News 27 nov 2018 Export to Japan: “Digitalization offers opportunities for Switzerland” The new head of Swiss Business Hub Japan, Claudio Mazzucchelli, wants to take advantage of new opportunities related to the increasing speed of d...
News 12 dez 2022 INTEGRA Biosciences to base half of its production activities in Switzerland Zizers - INTEGRA Biosciences is building a new production facility at its headquarters in the Greater Zurich Area. In future, more than half of t...
Rapport sectoriel 24 mar 2021 Rapport sectoriel: Technologies médicales en Corée La Corée importe plus de 60% de ses appareils médicaux. Cela représente d'importantes opportunités commerciales pour les exportateurs suisses.
Rapporti settoriali 24 mar 2021 Rapporto settoriale: medtech in Corea La quota di importazione nel settore dei dispositivi medici in Corea è superiore al 60%. Ciò offre grandi opportunità d’affari agli esportatori s...
Aktuell 26 jun 2018 Global Trade Briefing: Datenbank für Handelshürden In welchem Ihrer Zielmärkte gibt es neue Regulierungen, die Ihre Exporte voranbringen oder behindern könnten? Die verbesserte Datenbank «Global T...